Ondansetron leads antiemetic research.
Mahaney
F X
FX
D000970:Antineoplastic Agents / Q000009:adverse effects*; D003365:Costs and Cost Analysis; D006801:Humans; D009325:Nausea / Q000517:prevention & control*; D017294:Ondansetron / Q000627:therapeutic use*; D012701:Serotonin / Q000378:metabolism; D014839:Vomiting / Q000517:prevention & control*
D000970:Antineoplastic Agents; D012701:Serotonin; D017294:Ondansetron